Cara Therapeutics
Cara Therapeutics

Dividends • Cara Therapeutics

CARA

Cara Therapeutics Inc is a development-stage biotechnology company involved in the development of novel therapeutics to treat human diseases associated with inflammation, pain, and pruritus. Cara's most advanced compound, CR845, aims to treat acute pain and pruritus. This patented compound has analgesic, anti-inflammatory, and antipruritic properties that can be used for multiple therapeutic applications. Additionally, Cara's objective is to use its proprietary drug-screening technology to develop a future pipeline of first-in-class molecules with analgesic and anti-inflammatory features.

See below the complete and updated table with all dividends paid and declared history, etc

Excluding Date
Payment
Value ($)
Frequency
3/27/2024
4/12/2024
0,215
Quarterly
1/4/2024
1/19/2024
0,215
Quarterly
9/28/2023
10/13/2023
0,215
Quarterly
6/29/2023
7/14/2023
0,2
Quarterly
3/30/2023
4/14/2023
0,2
Quarterly
1/5/2023
1/20/2023
0,2
Quarterly